^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    UMG2-CD3 BTCE

    i
    Other names: UMG2-CD3 BTCE
    Associations
    News
    Trials
    Company:
    Magna Graecia University
    Drug class:
    CD3 agonist, T-cell stimulant, CD1A inhibitor
    Related drugs:
    Associations
    News
    Trials